SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India informs about Financial Results

28 Jan 2015 Evaluate

Granules India has informed about the Financial Results, Results Press Release & a copy of the Limited Review Report for the period ended December 31, 2014.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

766.25 -4.65 (-0.60%)
25-Jun-2026 12:15 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1876.75
Dr. Reddys Labs. 1344.55
Cipla 1443.30
Zydus Lifesciences 1098.50
Lupin 2366.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: